Research recommendation(s) from an individual piece of guidance
- Guidance:
- Familial hypercholesterolaemia: identification and management
- Date issued:
Research recommendations coming out of this guidance
-
What is the clinical and cost effectiveness of using different thresholds of LDL‑C concentration in primary care case finding?
-
What are the long-term effects of statin therapy on sub-clinical atherosclerosis in children with FH who are treated with statin therapy?
-
What is the clinical effectiveness and safety of differing doses of lipid-modifying therapy in children with FH?
-
What are the appropriate indications, effectiveness and safety of LDL apheresis in people with heterozygous FH?
-
What are the implications of FH for the safety of a mother during pregnancy and what are the risks of fetal malformations attributable to pharmacological therapies
-
What is the utility of routine cardiovascular evaluation for asymptomatic people with FH?